Innovent Biologics (HK:1801) has released an update.
Innovent Biologics, Inc. announced successful passage of all proposed resolutions during their Annual General Meeting held on June 21, 2024, including the re-election of board members and the adoption of the fifteenth amended and restated memorandum and articles of association. Shareholders showed strong support for the direction of the company, with significant majority votes for all resolutions, indicating confidence in Innovent Biologics’ governance and future plans.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
